Trade ImmuCell - ICCC CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.19 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5 |
| Open | 4.83 |
| 1-Year Change | -4.73% |
| Day's Range | 4.83 - 5.09 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 5.00 | 0.17 | 3.52% | 4.83 | 5.09 | 4.83 |
| Feb 20, 2025 | 5.00 | 0.00 | 0.00% | 5.00 | 5.00 | 4.85 |
| Feb 19, 2025 | 5.02 | 0.01 | 0.20% | 5.01 | 5.16 | 5.01 |
| Feb 18, 2025 | 5.00 | -0.12 | -2.34% | 5.12 | 5.12 | 4.83 |
| Feb 14, 2025 | 5.00 | -0.14 | -2.72% | 5.14 | 5.14 | 4.98 |
| Feb 13, 2025 | 5.01 | -0.04 | -0.79% | 5.05 | 5.05 | 4.97 |
| Feb 12, 2025 | 5.04 | 0.01 | 0.20% | 5.03 | 5.04 | 5.03 |
| Feb 11, 2025 | 5.18 | 0.19 | 3.81% | 4.99 | 5.18 | 4.99 |
| Feb 10, 2025 | 5.17 | 0.18 | 3.61% | 4.99 | 5.20 | 4.99 |
| Feb 7, 2025 | 5.25 | 0.01 | 0.19% | 5.24 | 5.25 | 5.24 |
| Feb 6, 2025 | 5.15 | 0.23 | 4.67% | 4.92 | 5.19 | 4.92 |
| Feb 5, 2025 | 5.12 | 0.18 | 3.64% | 4.94 | 5.19 | 4.94 |
| Feb 4, 2025 | 4.99 | 0.03 | 0.60% | 4.96 | 5.08 | 4.81 |
| Feb 3, 2025 | 5.00 | 0.01 | 0.20% | 4.99 | 5.14 | 4.83 |
| Jan 31, 2025 | 5.20 | -0.02 | -0.38% | 5.22 | 5.37 | 4.99 |
| Jan 30, 2025 | 5.00 | -0.39 | -7.24% | 5.39 | 5.39 | 5.00 |
| Jan 29, 2025 | 5.24 | 0.67 | 14.66% | 4.57 | 5.24 | 4.57 |
| Jan 28, 2025 | 5.30 | 0.31 | 6.21% | 4.99 | 5.30 | 4.92 |
| Jan 27, 2025 | 5.11 | 0.01 | 0.20% | 5.10 | 5.11 | 5.10 |
| Jan 24, 2025 | 5.10 | 0.11 | 2.20% | 4.99 | 5.10 | 4.99 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
ImmuCell Company profile
About ImmuCell Corporation
ImmuCell Corporation is an animal health company. The Company is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. It expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The Company is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.
Financial summary
BRIEF: For the nine months ended 30 September 2021, ImmuCell Corporation revenues increased 19% to $13.8M. Net loss decreased 87% to $152K. Revenues reflect First Defense® product line segment increase of 44% to $9.5M, Other animal health segment increase of 83% to $186K, United States segment increase of 18% to $12.2M, Others segment increase of 28% to $1.6M.
Equity composition
Common Stock $.10 Par, 12/10, 8M auth., 3,261,148 issd., less 287,496 shs. in Treas. @ $635K. Insiders own 26.70%. PO 5/87, 966,000 Units (100 Common + 5 Warrants) @ $7/Unit by Stuart James. 7/90, 1-for-100 reverse stock split.
| Industry: | Biotechnology & Medical Research (NEC) |
56 Evergreen Drive
PORTLAND
MAINE 04103
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com